Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oryzon Genomics (ORY SM)
Watchlist
54
Analysis
Health Care
•
Spain
Oryzon Genomics, SA is a clinical stage biopharmaceutical company that develops epigenetics-based therapeutics.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oryzon Genomics
•
05 Jul 2023 20:50
•
Issuer-paid
Oryzon Genomics - Positive safety data for vafidemstat in PORTICO
Oryzon has announced positive aggregate safety data for vafidemstat, which is being evaluated in the ongoing PORTICO trial as a potential treatment...
Edison Investment Research
Follow
285 Views
Share
bullish
•
Oryzon Genomics
•
11 May 2023 22:42
•
Issuer-paid
Oryzon Genomics - Advancing on multiple clinical fronts in Q1
Oryzon has reported Q123 results highlighting its near-term strategic priorities, including a favourable interim analysis of its lead asset study,...
Edison Investment Research
Follow
224 Views
Share
bullish
•
Oryzon Genomics
•
04 Apr 2023 16:32
•
Issuer-paid
Oryzon Genomics - Promising PORTICO interim results
Oryzon has announced promising results from an interim analysis of the Phase IIb PORTICO study, a trial evaluating vafidemstat as a treatment for...
Edison Investment Research
Follow
271 Views
Share
bullish
•
Oryzon Genomics
•
16 Mar 2023 20:12
•
Issuer-paid
Oryzon Genomics - Clinical milestone reached with FRIDA initiation
Oryzon Genomics has announced it has enrolled the first patient in its Phase Ib FRIDA study investigating iadademstat in combination with Astellas’...
Edison Investment Research
Follow
457 Views
Share
bullish
•
Oryzon Genomics
•
14 Mar 2023 15:38
•
Issuer-paid
Oryzon Genomics - New clinical candidate expands CNS portfolio
Oryzon Genomics has nominated a new central nervous system (CNS) clinical development candidate, ORY-4001, for the treatment of rare CNS disorders...
Edison Investment Research
Follow
217 Views
Share
Previous
1
2
3
4
5
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x